Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis.
about
Filtration improves the performance of a high-throughput screen for anti-mycobacterial compoundsA dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosisTargeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitorsDiscovery and validation of new antitubercular compounds as potential drug leads and probes.High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.Multitarget drug discovery for tuberculosis and other infectious diseases.Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosisComparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis.Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.Influence of vehicles used for oral dosing of test molecules on the progression of Mycobacterium tuberculosis infection in mice.Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistenceEfficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.Novel Zinc(II) Complexes [Zn(atc-Et)₂] and [Zn(atc-Ph)₂]: In Vitro and in Vivo Antiproliferative Studies.In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxideSynthesis and Biological Activity of New Thiopyrano[2,3-d]thiazoles Containing a Naphthoquinone MoietyFighting tuberculosis: old drugs, new formulations.Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosisRapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.Evaluation of a 2-pyridone, KRQ-10018, against Mycobacterium tuberculosis in vitro and in vivo
P2860
Q28385193-3B8E250B-1E37-462F-9522-08C3C5F70C21Q28485999-B5347648-05F2-4CAE-AF0D-F04E1568A40EQ33292548-E9B8D675-62B3-4326-A9C1-62AC87DD66D1Q33498260-F486B410-EFB2-4CC6-A495-6B8516E35845Q33503956-20D8CC9C-1321-499F-8C34-9312084C4C93Q33854785-34BF3085-AE1F-458E-B6A2-7623AC170CF7Q34092117-93C0C8D6-8F93-4131-83DD-75D14582BD3DQ34737143-FE89B78A-C26F-4B05-BB4B-0DD474BE73EBQ35180731-D64E5F03-4325-4490-82E7-DEE450E775BEQ36094916-43C97B23-6FEA-430C-8365-6B25F51144DCQ36364233-F98BE0F0-D2A7-426E-A7D2-70CF36CD84FEQ36561241-DA840B55-D86E-4B05-80A5-AE1DA580C0FCQ36870749-3FAEAB87-3048-46D5-98B7-32691AFDE25FQ36939375-916CCEB3-4972-4805-AAE0-531408EE4EF0Q36953414-97F8644C-85DD-4356-A056-7D09B9091802Q36978177-15E7A4FE-7018-49F6-B1BB-58713B6ACC3FQ37579212-D4C1EA21-6662-4BA6-98DE-4AD6940678AFQ37722890-E511B230-5057-4C6E-9D11-03B67A80A058Q40259991-23428EA4-1A54-43A7-8450-1D335767C8B6Q42111994-D9135D86-D12B-4673-B29C-1C56FDF0A3CC
P2860
Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Rapid microbiologic and pharma ...... st Mycobacterium tuberculosis.
@ast
Rapid microbiologic and pharma ...... st Mycobacterium tuberculosis.
@en
Rapid microbiologic and pharma ...... st Mycobacterium tuberculosis.
@nl
type
label
Rapid microbiologic and pharma ...... st Mycobacterium tuberculosis.
@ast
Rapid microbiologic and pharma ...... st Mycobacterium tuberculosis.
@en
Rapid microbiologic and pharma ...... st Mycobacterium tuberculosis.
@nl
prefLabel
Rapid microbiologic and pharma ...... st Mycobacterium tuberculosis.
@ast
Rapid microbiologic and pharma ...... st Mycobacterium tuberculosis.
@en
Rapid microbiologic and pharma ...... st Mycobacterium tuberculosis.
@nl
P2093
P2860
P1476
Rapid microbiologic and pharma ...... st Mycobacterium tuberculosis.
@en
P2093
Anne J Lenaerts
Christine M Johnson
Dean C Crick
Erin E Zink
Hataichanok Scherman
Ian M Orme
Karen S Marietta
Linda B Adams
Veronica Gruppo
P2860
P304
P356
10.1128/AAC.50.4.1245-1250.2006
P407
P577
2006-04-01T00:00:00Z